Top Markets
Coin of the day
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
株式のランク #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
株価
$0.12164306
最終同期: 2024-11-11
時価総額
$38.53M
変化(1日)
-4.14%
変化(1年)
0.00%
AU
取引 PharmAust Limited (PAA)

カテゴリー

PharmAust Limited(PAA)の利益
Jun 2024 時点の利益 TTM: $-6.31M
PharmAust Limited の最新の財務報告によると、同社の現在の利益は $-6.31M です。2023 年には $-4.14M の利益を上げ、これは 2022 年の利益 $-1.18M と 減少 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
PharmAust Limited の利益の推移(2001 〜 2026)
各年末の利益
利益 変化
2026 (TTM) $-6.31M 0.00%
2024 $-6.31M 52.51%
2023 $-4.14M 251.26%
2022 $-1.18M 17.50%
2021 $-1.00M 6.70%
2020 $-939.77K -13.74%
2019 $-1.09M -41.67%
2018 $-1.87M 80.51%
2017 $-1.03M -64.63%
2016 $-2.93M 97.39%
2015 $-1.48M 19.24%
2014 $-1.24M 112.82%
2013 $-584.08K -86.59%
2012 $-4.35M -29.96%
2011 $-6.22M 1,573.65%
2010 $-371.45K 155.62%
2009 $-145.32K -97.37%
2008 $-5.53M -0.89%
2007 $-5.58M 173.13%
2006 $-2.04M -20.13%
2005 $-2.56M 42.56%
2004 $-1.80M 29.13%
2003 $-1.39M -33.40%
2002 $-2.09M 96.03%
2001 $-1.06M 0.00%
同業他社の利益
企業 利益 利益の差
$5.27B -83,669.91%
US
$1.95B -31,004.03%
NL
$1.61B -25,675.00%
AU
$-3.09B 48,807.15%
US
- -
CH